Growth Metrics

Core Laboratories (CLB) Total Current Liabilities (2022 - 2026)

Core Laboratories filings provide 5 years of Total Current Liabilities readings, the most recent being $104.7 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 0.97% to $104.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $104.7 million, a 0.97% increase, with the full-year FY2025 number at $106.0 million, up 3.48% from a year prior.
  • Total Current Liabilities hit $104.7 million in Q1 2026 for Core Laboratories, down from $106.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $106.0 million in Q4 2025 to a low of $84.2 million in Q3 2023.
  • Median Total Current Liabilities over the past 5 years was $97.6 million (2024), compared with a mean of $97.5 million.
  • Biggest five-year swings in Total Current Liabilities: decreased 14.58% in 2023 and later grew 21.36% in 2025.
  • Core Laboratories' Total Current Liabilities stood at $103.1 million in 2022, then dropped by 14.58% to $88.1 million in 2023, then increased by 16.29% to $102.4 million in 2024, then increased by 3.48% to $106.0 million in 2025, then dropped by 1.21% to $104.7 million in 2026.
  • The last three reported values for Total Current Liabilities were $104.7 million (Q1 2026), $106.0 million (Q4 2025), and $95.7 million (Q3 2025) per Business Quant data.